ENTEROME SA

Nov 07, 2019

Enterome Enters Research Collaboration With Major Cancer Center Focused on New Microbiome-derived Immunotherapies

Apr 03, 2019

Enterome Expands and Strengthens its Management Team

Mar 27, 2019

Enterome to Present Data on Its Innovative Microbiome-derived Molecular Mimicry Approach to Cancer Immunotherapy at AACR 2019

Mar 20, 2019

Enterome Announces Research Collaboration with Renowned US Cancer Institute Focused on New Microbiome-derived Cancer Immunotherapy

Oct 23, 2018

Enterome Signs Global Licensing, Co-development and Co-promotion Agreement with Takeda for the Treatment of Crohn's Disease

Aug 02, 2018

Enterome CEO to Present at Two Upcoming Investor Conferences in the United States

Jun 20, 2018

Enterome to Participate in the 2018 Microbiome Movement - Drug Development Summit in Boston

Jun 04, 2018

Enterome to Attend the Jefferies 2018 Global Healthcare Conference in New York

Jun 01, 2018

Enterome to Feature Promising Phase 1 Clinical Data With its Lead Candidate EB8018 for Crohn's Disease at the Digestive Disease Week 2018

Mar 12, 2018

Enterome to Present at the Cowen and Company 38th Annual Healthcare Conference

Jan 04, 2018

Enterome Raises EUR32 Million ($38.5 Million) in a Series D Financing

Oct 27, 2017

Enterome's EB8018, a First-in-class Drug Candidate Targeting Crohn's Disease, Successfully Completes Phase I Study in Healthy Volunteers

Sep 20, 2017

Enterome to Move its Research Laboratories to Genopole, France's First Biocluster